Carboplatin, Cas 41575-94-4

Carboplatin, CAS 41575-94-4 — carboplatin is a platinum-based antineoplastic agent used in chemotherapy; this listing is supplied as a 100mg size (see Size metadata) and originates from the manufacturer MOLEQULE-ON (New Zealand) with supplier EMDA.

Key specifications & features: white crystalline powder / powder for injection format; molecular formula C6H12N2O4Pt; commonly formulated into aqueous injection preparations (marketed injections are typically 10 mg/mL), and research/medical suppliers also offer 100 mg powder vials. Use the manufacturer lot documentation and COA for purity and handling details.

Primary use cases: systemic oncology treatment — approved and widely used for ovarian cancer and applied in regimens for small-cell and non-small-cell lung cancer, head and neck cancers, germ cell and certain bladder and testicular tumors; used alone or in combination chemotherapy protocols.

Mechanism & safety notes: platinum coordination compound that binds DNA and induces crosslinks, inhibiting DNA synthesis and triggering apoptosis. Dose-limiting toxicity is myelosuppression; compared with cisplatin, it generally shows reduced nephrotoxicity but pronounced hematologic effects. Carboplatin is a cytotoxic, prescription-only medicine — handle using appropriate PPE, prepare/dispense in certified containment/compounding facilities, follow manufacturer instructions for reconstitution, use, storage, and cytotoxic waste disposal.